Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Grunwald

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, David J Kuter, Ivy Altomare, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Acta Haematologica|February 12, 2025
Distress and Care Utilization in Patients with Myeloproliferative NeoplasmsRushil Virendra Patel, Danielle Boselli, Patrick L Meadors, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Leukemia & Lymphoma|February 2, 2022
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF)Aleksander L Chojecki, Kristyn Y DiSogra, Justin Arnall, et al.
Clinical and Translational Science|December 24, 2022
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemiaMichael Boyiadzis, Pinkal Desai, Nikki Daskalakis, et al.
Vaccine: X|April 6, 2023
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patientsZainab Shahid, Alicia L Patrick, Michelle L Wallander, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor TransplantationOlivia R Copelan, Srinivasa R Sanikommu, Jigar S Trivedi, et al.
Clinical Pharmacology and Therapeutics|September 25, 2019
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell TransplantJai N Patel, Issam S Hamadeh, Myra Robinson, et al.
Leukemia|October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter studySiddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, David J Kuter, Ivy Altomare, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Acta Haematologica|February 12, 2025
Distress and Care Utilization in Patients with Myeloproliferative NeoplasmsRushil Virendra Patel, Danielle Boselli, Patrick L Meadors, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Leukemia & Lymphoma|February 2, 2022
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF)Aleksander L Chojecki, Kristyn Y DiSogra, Justin Arnall, et al.
Clinical and Translational Science|December 24, 2022
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemiaMichael Boyiadzis, Pinkal Desai, Nikki Daskalakis, et al.
Vaccine: X|April 6, 2023
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patientsZainab Shahid, Alicia L Patrick, Michelle L Wallander, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor TransplantationOlivia R Copelan, Srinivasa R Sanikommu, Jigar S Trivedi, et al.
Clinical Pharmacology and Therapeutics|September 25, 2019
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell TransplantJai N Patel, Issam S Hamadeh, Myra Robinson, et al.
Leukemia|October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter studySiddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Pageof 13